{
    "Trade/Device Name(s)": [
        "BioFire Global Fever Panel",
        "BIOFIRE SHIELD Control Kit for the BioFire Global Fever Panel"
    ],
    "Submitter Information": "BioFire Defense, LLC",
    "510(k) Number": "K220870",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200043",
        "K202382"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QMV",
        "PMN"
    ],
    "Summary Letter Date": "March 24, 2022",
    "Summary Letter Received Date": "March 25, 2022",
    "Submission Date": "2022-03-24",
    "Regulation Number(s)": [
        "21 CFR 866.3966",
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Device to detect and identify selected microbial agents that cause acute febrile illness",
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "parisitology"
    ],
    "Analyte(s)": [
        "Chikungunya virus",
        "Dengue virus",
        "Leptospira spp.",
        "Plasmodium spp.",
        "Plasmodium falciparum",
        "Plasmodium vivax/ovale"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioFire FilmArray 2.0",
        "BioFire FilmArray Torch"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplexed nucleic acid amplification",
        "Nested PCR",
        "Melt analysis"
    ],
    "Methodologies": [
        "Qualitative multiplexed nucleic acid testing",
        "Nucleic acid amplification test"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BioFire Global Fever Panel and BIOFIRE SHIELD Control Kit, multiplexed nucleic acid assay for detection of acute febrile illness pathogens on BioFire FilmArray 2.0 and Torch systems",
    "Indications for Use Summary": "Qualitative, multiplexed nucleic acid-based test to detect chikungunya virus, dengue virus, Leptospira spp., and Plasmodium spp. (including differentiation of P. falciparum and P. vivax/ovale) from EDTA whole blood of individuals with suspected acute febrile illness, used with BioFire FilmArray 2.0 and Torch Systems; control kit intended for assayed quality control with the panel",
    "fda_folder": "Microbiology"
}